top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Science Corporation Raises $400M in Series D Financing at $3.5B Valuation to Advance Vision-Restoring Implants and Brain-Computer Interface Technology

1 day ago
1 min read

Updated: 8 hours ago

Alameda, CA, November 17, 2026 (Bloomberg) -- Science Corporation, a medical technology startup founded by former Neuralink president Max Hodak, has raised $400 million in a Series D financing round, bringing its reported valuation to $3.5 billion. Investors include Khosla Ventures, Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech. The financing will support the expansion and commercialization of the company's PRIMA retinal implant, a device designed to restore partial vision in patients with advanced age-related macular degeneration.


Read full article here.

 
 
 

Recent Posts

See All

Comments


Life Science Headlines
bottom of page